Establishment and chimera analysis of 129/SvEv- and C57BL/6-derived mouse embryonic stem cell lines

被引:118
作者
Auerbach, W
Dunmore, JH
Fairchild-Huntress, V
Fang, Q
Auerbach, AB
Huszar, D
Joyner, AL
机构
[1] NYU, Sch Med, Skirball Inst Biomol Med, HHMI, New York, NY 10016 USA
[2] NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA
[3] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA
[4] NYU, Sch Med, Dept Cell Biol, New York, NY USA
[5] Millennium Pharmaceut Inc, Cambridge, MA USA
关键词
D O I
10.2144/00295st04
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Hundreds of new mutant mouse lines are being produced annually using gene targeting and gene trap approaches in embryonic stem (ES) cells, and the number is expected to continue to grow as the human and mouse genome projects progress. The availability of robust ES cell lines and a simple technology for making chimeras is more attractive now than over before. We established several new ES cell lines from 129/SvEv and C57BL/6 mice and tested their ability to contribute to the germline following blastocyst injections and/or the less expensive and easier method of morula-ES cell aggregation. Using morula aggregation to produce chimeras, mice newly derived 129/SvEx and two C57BL/6 ES cell lines tested at early passages were found to contribute extensively to chimeras and produce germline-transmitting male chimeras. Furthermore, the two 129/vEv ES cell lines that were tested and one of the C57BL/6 ES cell lines were able to maintain these characterisatics after many passages in vitro. Our results indicate that the ability of ES cells to contribute strongly to chimeras following aggregation with outbred embryos is a general property of early passage ES cells and can be maintained for many passages. C56BL/6-derived ES cell lines, however, have a greater tendancy than 129-derived ES cell lines to lose their ability to colonize the germline.
引用
收藏
页码:1024 / +
页数:6
相关论文
共 12 条
  • [1] Benn PA, 1992, HUMAN CYTOGENETICS P, P91
  • [2] Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: Lessons from mouse knockouts
    Kokron, CM
    Bonilla, FA
    Oettgen, HC
    Ramesh, N
    Geha, RS
    Pandolfi, F
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (02) : 109 - 126
  • [3] Mice, gene targeting and behaviour: Than just genetic background - Commentary
    Lathe, R
    [J]. TRENDS IN NEUROSCIENCES, 1996, 19 (05) : 183 - 186
  • [4] Matise MP, 2000, GENE TARGETING PRACT, P101
  • [5] THE WNT-1 (INT-1) PROTOONCOGENE IS REQUIRED FOR DEVELOPMENT OF A LARGE REGION OF THE MOUSE-BRAIN
    MCMAHON, AP
    BRADLEY, A
    [J]. CELL, 1990, 62 (06) : 1073 - 1085
  • [6] DERIVATION OF COMPLETELY CELL CULTURE-DERIVED MICE FROM EARLY-PASSAGE EMBRYONIC STEM-CELLS
    NAGY, A
    ROSSANT, J
    NAGY, R
    ABRAMOWNEWERLY, W
    RODER, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8424 - 8428
  • [7] NAGY A, 2000, GENE TARGETING PRACT, P177
  • [8] Papaioannou V, 2000, PRACT APPROACH SER, V212, P133
  • [9] Gene disruption in mice: Models of development and disease
    Shastry, BS
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 181 (1-2) : 163 - 179
  • [10] Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
    Simpson, EM
    Linder, CC
    Sargent, EE
    Davisson, MT
    Mobraaten, LE
    Sharp, JJ
    [J]. NATURE GENETICS, 1997, 16 (01) : 19 - 27